OneMedNet’s regulatory-grade imaging Real-World Data (iRWD) now available in HealthVerity Marketplace™
OneMedNet (Nasdaq: ONMD) has integrated its imaging Real-World Data (iRWD) solution into the HealthVerity Marketplace, expanding access to comprehensive healthcare data for life sciences research. OneMedNet's network encompasses over 1,400 healthcare systems with access to 121 million clinical exams from 31 million unique patients.
This integration allows researchers to combine imaging data with medical claims, pharmacy, lab, and EHR data, providing a more complete view of patient journeys. The HealthVerity platform connects data from over 340 million de-identified individuals in a HIPAA-compliant environment.
The partnership enhances evidence generation capabilities by adding visual confirmation of disease progression, diagnostic markers, and therapy responses to structured data analysis. This collaboration aims to support more informed clinical development and commercialization decisions in healthcare research.
OneMedNet (Nasdaq: ONMD) ha integrato la sua soluzione di dati reali di imaging (iRWD) nel HealthVerity Marketplace, ampliando l'accesso a dati sanitari completi per la ricerca nelle scienze della vita. La rete di OneMedNet comprende oltre 1.400 sistemi sanitari con accesso a 121 milioni di esami clinici provenienti da 31 milioni di pazienti unici.
Questa integrazione consente ai ricercatori di combinare i dati di imaging con informazioni su reclami medici, farmaci, laboratori e cartelle cliniche elettroniche, offrendo una visione più completa del percorso del paziente. La piattaforma HealthVerity collega dati di oltre 340 milioni di individui anonimizzati in un ambiente conforme a HIPAA.
La collaborazione migliora le capacità di generazione di evidenze aggiungendo una conferma visiva della progressione della malattia, dei marker diagnostici e delle risposte alle terapie all'analisi dei dati strutturati. L'obiettivo è supportare decisioni più informate nello sviluppo clinico e nella commercializzazione nella ricerca sanitaria.
OneMedNet (Nasdaq: ONMD) ha integrado su solución de datos reales de imágenes (iRWD) en el HealthVerity Marketplace, ampliando el acceso a datos integrales de salud para la investigación en ciencias de la vida. La red de OneMedNet abarca más de 1,400 sistemas de salud con acceso a 121 millones de exámenes clínicos de 31 millones de pacientes únicos.
Esta integración permite a los investigadores combinar datos de imágenes con reclamos médicos, farmacia, laboratorio y datos de registros electrónicos de salud, proporcionando una visión más completa del recorrido del paciente. La plataforma HealthVerity conecta datos de más de 340 millones de personas desidentificadas en un entorno compatible con HIPAA.
La asociación mejora la generación de evidencia al añadir confirmación visual de la progresión de la enfermedad, marcadores diagnósticos y respuestas a terapias al análisis de datos estructurados. Esta colaboración busca apoyar decisiones más informadas en el desarrollo clínico y la comercialización en la investigación sanitaria.
OneMedNet(나스닥: ONMD)는 자사의 영상 실세계 데이터(iRWD) 솔루션을 HealthVerity Marketplace에 통합하여 생명과학 연구를 위한 포괄적인 의료 데이터 접근성을 확대했습니다. OneMedNet의 네트워크는 1,400개 이상의 의료 시스템을 포함하며, 3,100만 명의 고유 환자로부터 1억 2,100만 건의 임상 검사 데이터를 제공합니다.
이번 통합을 통해 연구자들은 영상 데이터와 의료 청구, 약국, 실험실, 전자의무기록(EHR) 데이터를 결합하여 환자의 진료 경로를 보다 완전하게 파악할 수 있습니다. HealthVerity 플랫폼은 HIPAA 준수 환경에서 3억 4,000만 명 이상의 익명화된 데이터를 연결합니다.
이번 파트너십은 질병 진행, 진단 마커, 치료 반응에 대한 시각적 확인을 구조화된 데이터 분석에 추가함으로써 근거 생성 능력을 강화합니다. 이 협력은 의료 연구에서 임상 개발과 상업화 결정을 보다 정보에 기반해 지원하는 것을 목표로 합니다.
OneMedNet (Nasdaq : ONMD) a intégré sa solution de données réelles d'imagerie (iRWD) dans le HealthVerity Marketplace, élargissant ainsi l'accès à des données de santé complètes pour la recherche en sciences de la vie. Le réseau de OneMedNet comprend plus de 1 400 systèmes de santé avec un accès à 121 millions d'examens cliniques provenant de 31 millions de patients uniques.
Cette intégration permet aux chercheurs de combiner les données d'imagerie avec les données de réclamations médicales, de pharmacie, de laboratoire et de dossiers médicaux électroniques, offrant une vue plus complète du parcours patient. La plateforme HealthVerity connecte des données de plus de 340 millions d'individus dé-identifiés dans un environnement conforme à la HIPAA.
Le partenariat renforce les capacités de génération de preuves en ajoutant une confirmation visuelle de la progression de la maladie, des marqueurs diagnostiques et des réponses aux thérapies à l'analyse des données structurées. Cette collaboration vise à soutenir des décisions plus éclairées dans le développement clinique et la commercialisation en recherche médicale.
OneMedNet (Nasdaq: ONMD) hat seine Imaging-Real-World-Daten (iRWD)-Lösung in den HealthVerity Marketplace integriert und erweitert damit den Zugang zu umfassenden Gesundheitsdaten für die Forschung in den Lebenswissenschaften. Das Netzwerk von OneMedNet umfasst über 1.400 Gesundheitssysteme mit Zugriff auf 121 Millionen klinische Untersuchungen von 31 Millionen einzigartigen Patienten.
Durch diese Integration können Forscher Bildgebungsdaten mit medizinischen Abrechnungen, Apotheken-, Labor- und elektronischen Gesundheitsakten (EHR)-Daten kombinieren und so einen umfassenderen Blick auf den Patientenverlauf erhalten. Die HealthVerity-Plattform verbindet Daten von über 340 Millionen anonymisierten Personen in einer HIPAA-konformen Umgebung.
Die Partnerschaft verbessert die Evidenzgenerierung, indem sie visuelle Bestätigungen des Krankheitsverlaufs, diagnostische Marker und Therapieansprechen zur strukturierten Datenanalyse hinzufügt. Ziel der Zusammenarbeit ist es, fundiertere Entscheidungen in der klinischen Entwicklung und Kommerzialisierung in der Gesundheitsforschung zu unterstützen.
- Network spans 1,400+ healthcare systems and provider sites
- Database includes 121 million clinical exams from 31 million unique patients
- Integration with HealthVerity Marketplace expands market reach
- Access to HealthVerity's ecosystem of 340 million de-identified individuals
- Strategic partnership enhances data monetization opportunities
- None.
Insights
OneMedNet's integration with HealthVerity Marketplace expands their imaging data reach, creating new opportunities in healthcare research.
OneMedNet's strategic integration with HealthVerity Marketplace represents a significant advancement in healthcare data accessibility. This partnership connects OneMedNet's extensive imaging network—spanning 1,400+ healthcare systems with 121 million clinical exams from 31 million unique patients—to HealthVerity's ecosystem encompassing 340 million de-identified individuals.
The integration addresses a fundamental limitation in healthcare analytics that the release explicitly highlights: imaging provides visual confirmation of disease progression, diagnostic markers, and therapy response that structured data alone cannot capture. By combining imaging with claims, pharmacy, lab, and EHR data in a HIPAA-compliant manner, researchers gain a more clinically nuanced and comprehensive view of patient journeys.
This partnership enhances data utility for specific applications mentioned in the release, including clinical development, commercial strategy, and regulatory submissions. For life sciences researchers, the addition of regulatory-grade imaging data provides critical clinical context previously unavailable through structured data alone.
From OneMedNet's perspective, this integration increases the visibility and accessibility of their imaging data within one of healthcare's largest data marketplaces. By joining HealthVerity's platform, OneMedNet's data becomes discoverable by life sciences researchers already utilizing the marketplace, potentially broadening their customer reach and use cases.
The collaboration aligns with the growing industry emphasis on leveraging diverse, integrated real-world data sources to support more sophisticated evidence generation throughout the research, development, and commercialization process.
Leading imaging source integration enhances access to comprehensive, interoperable data for life sciences research
MINNEAPOLIS, April 29, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading provider of regulatory-grade imaging Real-World Data (iRWD), today announced that its iRWD solution is now available in HealthVerity Marketplace™, enabling seamless integration of imaging data with broader real-world data (RWD) assets to enhance evidence generation in life sciences research.
The OneMedNet iRWD network, which spans more than 1,400 healthcare systems and provider sites and includes over 121 million clinical exams from 31 million unique patients, is now discoverable on the HealthVerity Marketplace™. As part of the industry’s most comprehensive real-world data ecosystem, this imaging data can be integrated with medical claims, pharmacy, lab, and EHR data to offer researchers a more complete and clinically nuanced view of the patient journey. Imaging provides context that structured data alone cannot—such as visual confirmation of disease progression, diagnostic markers, or response to therapy—opening new opportunities for more advanced, real-world evidence generation.
“The addition of OneMedNet’s regulatory-grade imaging data into HealthVerity Marketplace significantly enhances the depth of real-world data available to our clients,” said Andrew Kress, CEO of HealthVerity. “We continue to expand the scope of what’s possible using large-scale, data-driven evidence generation, allowing researchers to make more informed clinical development and commercialization decisions.”
HealthVerity Marketplace™ is backed by the nation’s largest verified healthcare and consumer data ecosystem, offering unparalleled access to over 340 million de-identified individuals. The platform enables precise patient journey insights by linking diverse data types in a HIPAA-compliant manner, supporting applications across clinical development, commercial strategy, and regulatory submissions.
“We are excited to bring OneMedNet’s regulatory-grade imaging data to the HealthVerity Marketplace™, expanding access to a unique modality within one of the most trusted ecosystems in healthcare,” said Aaron Green, President of OneMedNet. “Together, we offer researchers a deeper, more diverse view of the patient journey by integrating imaging into broader real-world data strategies.”
About HealthVerity
HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry’s largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making.
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,400 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information.
Learn more at www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com
SOURCE: ONEMEDNET CORPORATION
FAQ
What is OneMedNet's (ONMD) imaging Real-World Data network size in 2025?
How does OneMedNet's partnership with HealthVerity Marketplace benefit healthcare research?
What is the size of HealthVerity's data ecosystem that ONMD is joining?
What unique value does OneMedNet's imaging data add to HealthVerity Marketplace?
How will ONMD's integration affect clinical development and research?
